550 related articles for article (PubMed ID: 10935653)
21. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
[TBL] [Abstract][Full Text] [Related]
22. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome.
Häfner HM; Moehrle M; Eder S; Trilling B; Röcken M; Breuninger H
Eur J Surg Oncol; 2008 Jun; 34(6):680-6. PubMed ID: 17716851
[TBL] [Abstract][Full Text] [Related]
23. Conservative Re-excision is a Safe and Simple Alternative to Radical Resection in Revision Surgery for Dermatofibrosarcoma Protuberans.
Snow H; Davies E; Strauss DC; Smith M; Hayes AJ
Ann Surg Oncol; 2020 Mar; 27(3):919-923. PubMed ID: 31664620
[TBL] [Abstract][Full Text] [Related]
24. Malignancy arising within cutaneous tattoos: case of dermatofibrosarcoma protuberans and review of literature.
Reddy KK; Hanke CW; Tierney EP
J Drugs Dermatol; 2011 Aug; 10(8):837-42. PubMed ID: 21818504
[TBL] [Abstract][Full Text] [Related]
25. Dermatofibrosarcoma protuberans.
Garcia C; Clark RE; Buchanan M
Int J Dermatol; 1996 Dec; 35(12):867-71. PubMed ID: 8970843
[TBL] [Abstract][Full Text] [Related]
26. Dermatofibrosarcoma protuberans: a rare entity and review of the literature.
Stamatakos M; Fyllos A; Siafogianni A; Ntzeros K; Tasiopoulou G; Rozis M; Kontzoglou K
J BUON; 2014; 19(1):34-41. PubMed ID: 24659640
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases.
Shah KK; McHugh JB; Folpe AL; Patel RM
Am J Surg Pathol; 2018 Mar; 42(3):413-419. PubMed ID: 29240584
[TBL] [Abstract][Full Text] [Related]
28. Clinical and pathological analysis of dermatofibrosarcoma protuberans with long-term follow-up.
Shi X; Tan Q
J Plast Reconstr Aesthet Surg; 2020 Jun; 73(6):1143-1150. PubMed ID: 32201322
[TBL] [Abstract][Full Text] [Related]
29. Dermatofibrosarcoma protuberans: surgical management of a challenging mesenchymal tumor.
Wiesmueller F; Agaimy A; Perrakis A; Arkudas A; Horch RE; Grützmann R; Vassos N
World J Surg Oncol; 2019 May; 17(1):90. PubMed ID: 31138233
[TBL] [Abstract][Full Text] [Related]
30. [Realization of clinical diagnoses and treatment for dermatofibrosarcoma protuberans].
Cai H; Shi YQ; Wang YN; Zhu HY; Mo SJ
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):678-82. PubMed ID: 15329259
[TBL] [Abstract][Full Text] [Related]
31. Dermatofibrosarcoma protuberans: our 10-year experience on 80 patients.
Zhou X; Sun D; Liu Y; Sun Q; Yuan Z; Luo X; Yang J; Chen J
J Dermatolog Treat; 2020 Sep; 31(6):554-558. PubMed ID: 31116621
[No Abstract] [Full Text] [Related]
32. Dermatofibrosarcoma protuberans: review of 20-years experience.
Ruiz-Tovar J; Fernández Guarino M; Reguero Callejas ME; Aguilera Velardo A; Arano Bermejo J; Cabañas Navarro L
Clin Transl Oncol; 2006 Aug; 8(8):606-10. PubMed ID: 16952850
[TBL] [Abstract][Full Text] [Related]
33. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
Garcia C; Viehman G; Hitchcock M; Clark RE
Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
[TBL] [Abstract][Full Text] [Related]
34. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
Reimann JD; Fletcher CD
Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
[TBL] [Abstract][Full Text] [Related]
35. [Surgical treatment of dermatofibrosarcoma protuberans using wide local excision combined with Mohs micrographic surgery].
Xiang Q; Lu W; He X; Li H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Nov; 25(11):1350-3. PubMed ID: 22229192
[TBL] [Abstract][Full Text] [Related]
36. Sarcomatous dermatofibrosarcoma protuberans metastasized to the lung: preservation of CD34 expression in tumor cells.
Ohtani N; Fukusato T; Tezuka F
Pathol Int; 1998 Dec; 48(12):989-93. PubMed ID: 9952345
[TBL] [Abstract][Full Text] [Related]
37. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.
Prieto VG; Reed JA; Shea CR
J Cutan Pathol; 1994 Aug; 21(4):324-9. PubMed ID: 7528229
[TBL] [Abstract][Full Text] [Related]
38. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of surgery for dermatofibrosarcoma protuberans.
Chang CK; Jacobs IA; Salti GI
Eur J Surg Oncol; 2004 Apr; 30(3):341-5. PubMed ID: 15028319
[TBL] [Abstract][Full Text] [Related]
40. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors.
Ding J; Hashimoto H; Enjoji M
Cancer; 1989 Aug; 64(3):721-9. PubMed ID: 2545326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
